530 results on '"Eluri, Swathi"'
Search Results
2. Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years
3. Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett’s esophagus: results from a multicenter prospective registry
4. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia
5. Association between time from esophageal food impaction to endoscopy and adverse events
6. Esophageal Candidiasis Is Strongly Associated With Treatment Response to Topical Steroids in Eosinophilic Esophagitis and Could Be a Marker of Adherence
7. CSTB and FABP5 Serum mRNA Differentiate Histologically Active and Inactive Patients With Eosinophilic Esophagitis
8. Higher Body Mass Index Is Associated With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis
9. Eosinophilic esophagitis patients with multiple atopic conditions: Clinical characteristics and treatment response to topical steroids
10. Can Flip-Chart Assisted Maternal Education Improve Essential New Born Care Knowledge and Skills? A Randomized Controlled Trial
11. Loss to Follow-Up and Health Care Utilization After Initial Diagnosis of Eosinophilic Esophagitis
12. Management of Dysplastic Barrett’s Esophagus and Early Esophageal Adenocarcinoma
13. A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients
14. Older patients with eosinophilic esophagitis have high treatment response to topical steroids
15. Epidemiologic and Economic Burden of Achalasia in the United States
16. Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett’s Esophagus Surveillance After Endoscopic Therapy
17. Gender and Nationality Trends in Manuscripts Published in Prominent Gastroenterology Journals Between 1997 and 2017
18. EoE Down Under Is Still EoE: Variability in Provider Practice Patterns in Australia and New Zealand Among Pediatric Gastroenterologists
19. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett’s Esophagus After Endoscopic Therapy
20. Next-generation endoscopic probe for detection of esophageal dysplasia using combined OCT and angle-resolved low-coherence interferometry
21. Reduced Esophageal Contractility Is Associated with Dysplasia Progression in Barrett’s Esophagus: A Multicenter Cohort Study
22. Combination Therapy With Elimination Diet and Corticosteroids Is Effective for Adults With Eosinophilic Esophagitis
23. Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis
24. Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years
25. Clinical Features and Treatment Response to Topical Steroids in Ethnic and Racial Minority Patients With Eosinophilic Esophagitis
26. S467 Esophageal Candidiasis Is Strongly Associated With Treatment Response to Topical Steroids in Eosinophilic Esophagitis and Could Be a Marker of Adherence
27. S454 Performing Esophageal Biopsies During Upper Endoscopy for Esophageal Food Impaction Is Unlikely to Cause Complications
28. S596 Using In-Depth Patient Interviews to Understand Patient Perspectives and Experience on Barrett’s Esophagus Screening
29. S595 Primary Care Provider Perspectives on Facilitators and Barriers to Barrett’s Screening: Results from a Qualitative Study
30. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?
31. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis
32. Endoscopic eradication therapy in Barrett’s esophagus
33. Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis
34. Barrett's esophagus: diagnosis and management
35. Clinical Features and Treatment Response to Topical Steroids in Ethnic and Racial Minority Patients With Eosinophilic Esophagitis.
36. Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus.
37. Feeding Tube Placement, Complications, and Treatment Responses in a Large Eosinophilic Esophagitis Patient Population.
38. Distribution and Characteristics of Colonic Diverticula in a United States Screening Population
39. Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
40. Increased Risk of Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy
41. Increasing Rates of Esophageal Stricture and Dilation Over Two Decades in Eosinophilic Esophagitis
42. Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression
43. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease
44. Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis
45. Higher Body Mass Index Is Associated With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis
46. S400 A Cost Utility Model Supports Changes in Post-Treatment Surveillance Associated With the 2022 American College of Gastroenterology Guidelines
47. S498 The Eosinophilic Esophagitis Patient With Multiple Atopic Conditions: Clinical Characteristics and Treatment Response to Topical Steroids
48. S502 Clinical Features and Treatment Response to Topical Steroids in Ethnic and Racial Minority Patients With Eosinophilic Esophagitis
49. Association between eosinophilic esophagitis and esophageal dysmotility: A systematic review and meta‐analysis
50. Family history of inflammatory bowel disease among patients with ulcerative colitis: A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.